Inotropic, chronotropic, and arrhythmogenic effects of dopamine on the isolated working heart of rabbit

Journal of Physiological Sciences

Volumn 57, Issue 3, 2007, Pages 147-157

  Wakita, Yoshiakira ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Arrhythmogenic effect of dopamine; Chronotropic effect of dopamine; Inotropic effect of dopamine; Isolated rabbit heart; Perfusion method

Indexed keywords

DOPAMINE; NORADRENALIN; OXIDOPAMINE; RESERPINE; TYRAMINE;

ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CHRONOTROPISM; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAM; HEART ATRIUM ARRHYTHMIA; HEART CONTRACTION; HEART DENERVATION; HEART LEFT ATRIUM PRESSURE; HEART PERFUSION; HEART RATE; HEART RIGHT ATRIUM PRESSURE; HEART VENTRICLE EXTRASYSTOLE; HEART WORK; INOTROPISM; ISOLATED HEART; MALE; NONHUMAN; RABBIT; SYMPATHETIC NERVE; VENOUS RETURN;

ANIMALS; ARRHYTHMIA; BLOOD PRESSURE; CARDIOTONIC AGENTS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; HEART RATE; MALE; MONITORING, PHYSIOLOGIC; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION; NOREPINEPHRINE; OXIDOPAMINE; RABBITS; RESERPINE; SYMPATHECTOMY, CHEMICAL; SYMPATHOLYTICS;

EID: 34250882096     PISSN: 18806546     EISSN: None     Source Type: Journal    
DOI: 10.2170/physiolsci.RP003607     Document Type: Article

References (48)

1. Zimmer HG. The isolated perfused heart and its pioneers. News Physiol Sci. 1998;13:203-10.
2. Doring HJ. The isolated perfused heart according to Langendorff technique-function-application. Physiol Bohemoslov. 1990;39:481-504.
3. Kodama S. Device for perfusing an isolated rabbit-heart. Kumamoto Med J. 1961;14:119-26.
4. Kodama S. A method of perfusing an isolated rabbit-heart, with simultaneous pressure recordings of the aorta, vena cava, pulmonary artery and pulmonary vein. Tohoku J Exp Med. 1966;90:97-103.
5. Kodama S. Some notes on the method of perfusing an isolated rabbit-heart. Tohoku J Exp Med. 1967;92:243-6.
6. Kodama S. Simple method of measuring the oxygen consumption of a rabbit-heart perfused in vitro. Tohoku J Exp Med. 1969;97:181-5.
7. Bejrablaya D, Burn JH, Walker JM. The action of sympathomimetic amines on heart rate in relation to the effect of reserpine. Br J Pharmacol Chemother. 1958;13:461-6.
8. Endoh M. Effects of dopamine on sinus rate and ventricular contractile force of the dog heart in vitro and in vivo. Br J Pharmacol. 1975;55:475-86.
9. Mugelli A, Ledda F, Mantelli L, Torrini M, Maccioni T. Studies on the positive inotropic effect of dopamine in the guinea-pig heart.. Naunyn Schmiedebergs Arch Pharmacol. 1977;301:49-55.
10. Tenner TE Jr, McNeill JH, Carrier O Jr. The role of calcium in supersensitivity to the inotropic effects of norepinephrine. Eur J Pharmacol. 1978;50:359-67.
11. Meisheri KD, Tenner TE Jr, McNeill JH. Reserpine-induced supersensitivity to the cardiac effects of agonists. Life Sci. 1979;24:473-80.
12. Habuchi Y, Tanaka H, Yamamoto T, Komori T, Nishio M, Yoshimura M. The mechanisms underlying heart stimulation by dopamine, with special reference to direct and indirect beta adrenoceptor stimulation. Clin Exp Hypertens. 1997;19:141-54.
13. Nadeau RA, de Champlain J, Tremblay GM. Supersensitivity of the isolated rat heart after chemical sympathectomy with 6-hydroxydopamine. Can J Physiol Pharmacol. 1971;49:36-44.
14. Shibata S, Kuchii M, Kurahashi K. The supersensitivity of isolated rabbit atria and aortic strips produced by 6-hydroxydopamine. Eur J Pharmacol. 1972;18:271-80.
15. Brown L. Pharmacological responses to dopamine in isolated guinea-pig cardiovascular tissues: mechanisms of action. Arch Int Pharmacodyn Ther. 1990;308:47-62
16. Wallace AG, Skinner SN Jr, Mitchell JH. Hemodynamic determinants of the maximal rate of rise of left ventricular pressure. Am J Physiol. 1963;205:30-6.
17. Mason DT. Usefulness and limitations of the rate of rise of intraventricular pressure (dP/dt) in the evaluation of myocardial contractility in man. Am J Cardiol. 1969;23:516-27.
18. Carroll JD, Hess OM. Assessment of normal and abnormal cardiac function. In: Zipes DP, Libby P, Bonow RO, Braunwald E, editors. Braunwald's Heart Disease. vol. 1. Philadelphia: W.B.Sanders Co. 2005; p. 491-507.
19. Boniface KJ, Brodie OJ, Walton RP. Resistance strain gauge arches for direct measurement of heart contractile force in animals. Proc Soc Exp Biol Med. 1953;48:263-6.
20. Cotton MV, Bay E. Direct measurement of changes in cardiac contractile force relationship of such measurements to stroke work, isometric pressure gradient and other parameters of cardiac function. Am J Physiol. 1956;187:122-34.
21. Hoffman BF, Bindler E, Suckling EE. Postextrasystolic potentiation of contraction in cardiac muscle. Am J Physiol. 1956;183:95-102.
22. Meijler FL, Bogaard FVD, Twell LHVD, Durrer D. Postextrasystolic potentiation in the isolated rat heart. Am J Physiol. 1962;202:631-5.
23. Dubin D. Rhythm, Part I: Arrhythmias of focal origin. In: Rapid interpretation of EKG's 6th ed. Florida: Cover Pub. Com. 2000; p. 97-172.
24. Olgin JE, Zipes DP. Specific arrhythmias: diagnosis and treatment. In: Zipes DP, Libby P, Bonow RO, Braunwald E, editors. Braunwald's Heart Disease. vol. 1. Philadelphia: W.B.Sanders Co. 2005; p. 803-64.
25. Neely JR, Liebermeister H, Battersby EJ, Morgan HE. Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol. 1967;212:804-14.
26. Goldberg LI. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev. 1972;24:1-29.
27. Horwitz D, Fox SM, Goldberg LI. Effects of dopamine in man. Circ Res. 1962;10:237-43.
28. McDonald RH Jr, Goldberg LI. Analysis of the cardiovascular effects of dopamine in the dog. J Pharmacol Exp Ther. 1963;140:60-6.
29. Alousi AA. Cardiovascular effects of dopamine in the normal and failing heart of experimental animals. Recent Adv Stud Cardiac Struct Metab. 1975;6:291-300.
30. Motomura S, Brodde OE, Schümann HJ. No evidence for involvement of dopaminergic receptors in the positive inotropic action of dopamine on the isolated rabbit papillary muscle. Jpn J Pharmacol. 1978;28:145-53.
31. Brodde OE, Inui J, Motomura S, Schümann HJ. The mode of direct action of dopamine on the rabbit heart.. J Cardiovasc Pharmacol. 1980;2:567-82.
32. Wagner J, Schümann HJ, Knorr A, Rohm N, Reidemeister JC. Stimulation by adrenaline and dopamine but not by noradrenaline of myocardial alpha-adrenoceptors mediating positive inotropic effects in human atrial preparations. Naunyn Schmiedebergs Arch Pharmacol. 1980;312:99-102.
33. 2+ current in single atrial and ventricular myocytes of the rat. Br J Pharmacol. 1997;121:1247-54.
34. Ouedraogo L, Magnon M, Sawadogo L, Tricoche R. Receptors involved in the positive inotropic action induced by dopamine on the ventricle of a 7-day-old chick embryo heart.. Fundam Clin Pharmacol. 1998;12:133-42.
35. Habuchi Y, Tanaka H, Nishio M, Yamamoto T, Komori T, Morikawa J, Yoshimura M. Dopamine stimulation of cardiac ?-adrenoceptors: the involvement of sympathetic amine transporters and the effect of SKF38393. Brit J Pharmacol. 1997;122:1669-78.
36. Papp JG, Szekeres L. The arrhythmogenic action of sympathomimetic amines. Eur J Pharmacol. 1968;3:4-14.
37. Murnaghan MF. The effect of sympathomimetic amines on the ventricular fibrillation threshold in the rabbit isolated heart. Br J Pharmacol. 1975;53:3-9.
38. Tiller JW, Dowling JT, Tung LH, Maquire KP, Rand MJ, Davies BM. Tyramine-induced cardiac arrhythmias. N Engl J Med. 1985;313:266-7.
39. Katz RL, Lord CO, Eakins KE. Anesthetic-dopamine cardiac arrhythmias and their prevention by beta adrenergic blockade. J Pharmacol Exp Ther. 1967;158:40-5.
40. James MA, Jones JV. Effect of different levels of briefly sustained ventricular pressure on arrhythmia in the isolated working rat heart. Clin Sci. 1991;81:715-21.
41. Bednarski RM, Muir WW. Arrhythmogenicity of dopamine, dobutamine, and epinephrine in thiamylal-halothane anesthetized dogs. Am J Vet Res. 1983;44:2341-3
42. Goldberg LI, Rajfer SI. Dopamine receptors: applications in clinical cardiology. Circulation. 1985;72:245-8.
43. Goldberg LI. The role of dopamine receptors in the treatment of congestive heart failure. J Cardiovasc Pharmacol. 1989;14 Suppl 5:S19-27.
44. Goldberg LI. Pharmacological bases for the use of dopamine and related drugs in the treatment of congestive heart failure. J Cardiovasc Pharmacol. 1989;14 Suppl 8:S21-8.
45. Pastenak RC, Braunwald E. 202 Acute myocardial infarction. In Isselbacher KJ, Martin JB, Braunwald E, Fauci AS, Wilson JD, Kasper DL. editors. Harrison's Principles of Internal Medicine. 13th ed. New York: McGraw-Hill, Inc. 1994; p. 1066-77.
46. Reikeras O, Gunnes P, Sorlie D, Ekroth R, Mjos OD. Hemodynamic and metabolic effects of dopamine and insulin during acute left ventricular failure in dogs. J Cardiovasc Pharmacol. 1986;8:303-8.
47. Paterna S, Di Pasquale P, Antona A, Damico C, Listro G, Bucca V, Palazzoadriano M, Arrostuto A, Cannavo MG, Scalzo S. Effects of dopamine on isolated failing rat heart.. Int J Tissue React. 1994;16:243-50.
48. Endoh M, Hori M. Acute heart failure: inotropic agents and their clinical uses. Expert Opin Pharmacother. 2006;7:2179-202.